Xa inhibition and coagulation activity—the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals-Reference-Cited by-同舟云学术

Xa inhibition and coagulation activity—the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals

Published:2008-03 Issue:3 Volume:155 Page:493.e1-493.e8
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Oldgren Jonas,Johnston Nina,Siegbahn Agneta

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Coronary plaque disruption;Falk;Circulation,1995

2. Recognition of the importance of embolization in atherosclerotic vascular disease;Topol;Circulation,2000

3. Atherosclerosis—an inflammatory disease;Ross;N Engl J Med,1999

4. Pathogenic mechanisms in unstable angina;Maseri;Heart,1999

5. Haemostatic variables in patients with unstable angina;al-Nozha;Int J Cardiol,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels;Frontiers in Pharmacology;2024-07-12

2. Neuraxial blocks and spinal haematoma: Review of 166 case reports published 1994–2015. Part 1: Demographics and risk-factors;Scandinavian Journal of Pain;2017-04-01

3. Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency;Journal of General Internal Medicine;2015-07-25

4. Low-molecular-weight heparin pharmacokinetics: a dual absorption model approach;Int. Journal of Clinical Pharmacology and Therapeutics;2013-06-01

5. Gender Differences in Anticoagulation and Antithrombotic Therapy;Sex and Gender Differences in Pharmacology;2012-09-05